MLLBX | SSFQX | MLLBX / SSFQX | |
Total Expense Ratio | 1.45 | 0.59 | 246% |
Annual Report Gross Expense Ratio | 1.63 | 0.76 | 214% |
Fund Existence | 20 years | 3 years | - |
Gain YTD | 5.065 | 6.134 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 546M | 1.49B | 37% |
Annual Yield % from dividends | 2.72 | 3.34 | 81% |
Returns for 1 year | 3.86 | 7.46 | 52% |
Returns for 3 years | 9.39 | 13.08 | 72% |
Returns for 5 years | 6.35 | N/A | - |
Returns for 10 years | 23.42 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 26.52 | 0.09 | +0.35% |
First Trust Nasdaq Pharmaceuticals ETF | |||
XSOE | 34.83 | 0.09 | +0.26% |
WisdomTree EmMkts ex-Stt-Ownd EntrprsETF | |||
PFL | 8.52 | 0.01 | +0.12% |
PIMCO Income Strategy Fund | |||
DABS | 50.68 | -0.06 | -0.12% |
Doubleline Asset-Backed Securities ETF | |||
BUZZ | 31.72 | -0.16 | -0.50% |
VanEck Social Sentiment ETF |